Opportunity radar
4,186,134 patents indexed · 165,974,948 citations · issued 2005-01-04 → 2026-05-05
Showing50 of 30,058
Pharma (A61K)Therapy methods (A61P)Med devices (A61M)Agriculture (A01)Hand tools (B25)Consumer (A47)Energy (H01M)AI / ML (G06N)
| Patent # | Title | Assets | Issued | Expires | Fwd cites | Score |
|---|---|---|---|---|---|---|
| 12544381 | Topical formulation for JAK inhibitor | 🖼🧊📄§ | 2026-02-10 | 2045-04-05 | 0 | 31 |
| 12543740 | Micellar disinfectants | 🖼🧊📄§ | 2026-02-10 | 2041-02-26 | 0 | 31 |
| 12544366 | Combination of endocannabinoid and mTOR inhibitors in the treatment of neuroendocrine neoplasms | 🖼🧊📄§ | 2026-02-10 | 2043-05-17 | 0 | 31 |
| 12544372 | Methods of treating rheumatoid arthritis, chronic spontaneous urticaria, and systemic lupus erythematosis using an inhibitor of Bruton's tyrosine kinase | 🖼🧊📄§ | 2026-02-10 | 2041-07-21 | 0 | 31 |
| 12545916 | Allele-specific silencing therapy for DFNA9 using antisense oligonucleotides | 🖼🧊📄§ | 2026-02-10 | 2040-10-29 | 0 | 31 |
| 12544333 | Lipid vesicle compositions with penetration enhancing agents | 🖼🧊📄§ | 2026-02-10 | 2044-02-02 | 0 | 31 |
| 12544377 | Compounds, compositions and methods of treating or preventing acute lung injury | 🖼🧊📄§ | 2026-02-10 | 2043-12-22 | 0 | 31 |
| 12545688 | Camptothecin derivative and conjugate thereof | 🖼🧊📄§ | 2026-02-10 | 2040-09-17 | 0 | 31 |
| 12545729 | Anti-TREM2 agonist antibodies and antigen-binding fragments thereof that can increase levels of soluble TREM2 in serum and brain tissue | 🖼🧊📄§ | 2026-02-10 | 2045-06-27 | 0 | 31 |
| 12544404 | Compositions and methods for treating bone injury | 🖼🧊📄§ | 2026-02-10 | 2039-09-17 | 0 | 31 |
| 12544411 | Pharmaceutical composition for preventing or treating cancer, comprising Weissella cibaria WIKIM28 as active ingredient | 🖼🧊📄§ | 2026-02-10 | 2039-11-29 | 0 | 31 |
| 12545906 | Methods and compositions for selection of functional aptamers | 🖼🧊📄§ | 2026-02-10 | 2039-09-27 | 0 | 31 |
| 12544391 | CD73 inhibitors | 🖼🧊📄§ | 2026-02-10 | 2040-07-15 | 0 | 31 |
| 12545657 | Small-molecule modulators of the orphan nuclear receptor TLX | 🖼🧊📄§ | 2026-02-10 | 2041-12-22 | 0 | 31 |
| 12544348 | Methods for treating APOE4/4-associated disorders | 🖼🧊📄§ | 2026-02-10 | 2039-04-12 | 0 | 31 |
| 12539327 | Norovirus S particle based vaccines and methods of making and using same | 🖼🧊📄§ | 2026-02-03 | 2043-10-19 | 0 | 31 |
| 12540157 | Oxysterols and methods of use thereof | 🖼🧊📄§ | 2026-02-03 | 2043-11-09 | 0 | 31 |
| 12539297 | Composition for inhibiting cancer metastasis and treating cancer | 🖼🧊📄§ | 2026-02-03 | 2042-05-11 | 0 | 31 |
| 12539320 | Composition for improving eyesight | 🖼🧊📄§ | 2026-02-03 | 2043-04-13 | 0 | 31 |
| 12540174 | Kits and containers for treating vimentin expressing tumors | 🖼🧊📄§ | 2026-02-03 | 2042-10-07 | 0 | 31 |
| 12539316 | Compositions and methods for stem cell transplant | 🖼🧊📄§ | 2026-02-03 | 2039-04-11 | 0 | 31 |
| 12539296 | Montelukast for the treatment of erosive hand osteoarthritis | 🖼🧊📄§ | 2026-02-03 | 2039-11-25 | 0 | 31 |
| 12540184 | Association of polyclonal antibodies and anti-PD1 or anti-PDL1 antibodies for the treatment of cancer | 🖼🧊📄§ | 2026-02-03 | 2040-04-28 | 0 | 31 |
| 12539302 | Methods and compositions for the treatment of hair loss | 🖼🧊📄§ | 2026-02-03 | 2043-10-26 | 0 | 31 |
| 12539278 | Nanocomposite particle and uses thereof | 🖼🧊📄§ | 2026-02-03 | 2040-09-01 | 0 | 31 |
| 12540179 | Compositions and methods for treating cancer with anti-ROR1 immunotherapy | 🖼🧊📄§ | 2026-02-03 | 2042-08-18 | 0 | 31 |
| 12539274 | Zinc meloxicam complex microparticle multivesicular liposome formulations and processes for making the same | 🖼🧊📄§ | 2026-02-03 | 2041-06-10 | 0 | 31 |
| 12540181 | Anti-CD19/anti-CD3 bispecific antibody, T cells secreting the same, method of preparation and use thereof | 🖼🧊📄§ | 2026-02-03 | 2041-02-16 | 0 | 31 |
| 12540191 | Engineered immune cells targeting BCMA and their uses thereof | 🖼🧊📄§ | 2026-02-03 | 2043-09-29 | 0 | 31 |
| 12540334 | Gene therapy for Alzheimer's disease | 🖼🧊📄§ | 2026-02-03 | 2040-05-21 | 0 | 31 |
| 12540323 | Nucleic acid, pharmaceutical composition, conjugate, preparation method, and use | 🖼🧊📄§ | 2026-02-03 | 2040-05-21 | 0 | 31 |
| 12539308 | Immune-enhancing RNAs for combination with chimeric antigen receptor therapy | 🖼🧊📄§ | 2026-02-03 | 2039-01-08 | 0 | 31 |
| 12539319 | Lactobacillus delbrueckii subsp. lactis CKDB001 strain, and composition for prevention, amelioration, or treatment of non-alcoholic fatty liver comprising same | 🖼🧊📄§ | 2026-02-03 | 2041-03-23 | 0 | 31 |
| 12540172 | Therapeutic nanoconjugates comprising Stefin A and uses thereof | 🖼🧊📄§ | 2026-02-03 | 2040-01-16 | 0 | 31 |
| 12540166 | BNIP3 peptides for treatment of reperfusion injury | 🖼🧊📄§ | 2026-02-03 | 2040-05-08 | 0 | 31 |
| 12540143 | Methods and compositions for targeted protein degradation | 🖼🧊📄§ | 2026-02-03 | 2040-04-08 | 0 | 31 |
| RE050776 | Inhibitors of cyclin-dependent kinases | 🖼🧊📄§ | 2026-02-03 | 2043-03-09 | 0 | 31 |
| 12540168 | Human amylin analog polypeptides and methods of use | 🖼🧊📄§ | 2026-02-03 | 2044-05-10 | 0 | 31 |
| 12539305 | Methods of treating cancer with an mTOR inhibitor | 🖼🧊📄§ | 2026-02-03 | 2043-05-25 | 0 | 31 |
| 12540190 | Anti-BCMA antibody, antigen-binding fragment thereof and medical use thereof | 🖼🧊📄§ | 2026-02-03 | 2040-07-29 | 0 | 31 |
| 12540164 | Peptides for treatment and prevention of nonalcoholic fatty liver disease and fibrosis | 🖼🧊📄§ | 2026-02-03 | 2042-12-19 | 0 | 31 |
| 12539323 | Anti-psychotic composition and treatment methods | 🖼🧊📄§ | 2026-02-03 | 2041-12-01 | 0 | 31 |
| 12539284 | Aminoxy acid-based anti-cancer stem cell compounds and methods thereof | 🖼🧊📄§ | 2026-02-03 | 2040-11-23 | 0 | 31 |
| 12540136 | Pyrrolopyridine derivative and use thereof | 🖼🧊📄§ | 2026-02-03 | 2041-08-20 | 0 | 31 |
| 12538934 | Polyhalite enriched fish feed | 🖼🧊📄§ | 2026-02-03 | 2042-04-01 | 0 | 31 |
| 12540137 | N-1 branched alkyl ether substituted imidazo[4,5-c]quinoline compounds, compositions, and methods | 🖼🧊📄§ | 2026-02-03 | 2044-05-16 | 0 | 31 |
| 12539332 | Anti-viral and hepatic-targeted drugs | 🖼🧊📄§ | 2026-02-03 | 2040-10-19 | 0 | 31 |
| 12539264 | Composition comprising pentapeptide as active ingredient | 🖼🧊📄§ | 2026-02-03 | 2041-06-11 | 0 | 31 |
| 12540175 | Anti-ApoE antibodies | 🖼🧊📄§ | 2026-02-03 | 2044-02-08 | 0 | 31 |
| 12539335 | Tricyclic polypeptide conjugated drug and use thereof | 🖼🧊📄§ | 2026-02-03 | 2042-09-23 | 0 | 31 |